A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adam Cohen, MD
AMyC; Univ of Penn Perelman Center for Advanced Medicine
Principal Investigator - Brian GM Durie, MD
AMyC
Principal Investigator - Raymond Comenzo, MD
AMyC, Tufts University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope
Duarte, California, United States
- Stanford Cancer Institute
Stanford, California, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- Boston University Medical Center
Boston, Massachusetts, United States
- John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States
- Columbia University
New York, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Oregon Health and Sciences University
Portland, Oregon, United States
- Abramson Cancer Center at the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2013
- Primary completion
- 31 Dec 2016
- Completion
- 31 Jul 2017
- Last update posted
- 18 Oct 2017
- Registered enrollment
- 32
- Registry id
- NCT01789242
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.